The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue

PPAR¿ is obligatory for fat mass generation and is thought to determine the amount of TAG stored per fat cell. We investigated whether ligand availability for PPAR¿ is rate limiting in fat mass generation and substrate metabolism. Twenty healthy men (20¿29 years) were randomly assigned to receive the PPAR¿ ligand rosiglitazone (RSG) (8 mg/d) (n 10) or a placebo (n 10) during a stay of 7 d in a respiration chamber. Food intake was ad libitum, resulting in positive energy balances of 32·2 MJ (placebo) and 44·7 MJ (RSG). Fat cell size and expression of PPAR¿, adipocyte fatty acid-binding protein (aP2), adipsin, adiponectin and fasting-induced adipose factor (FIAF) were determined in subcutaneous abdominal fat biopsies. The total amount of fat stored and the amount of TAG per fat cell were not different between groups. For the entire group, fat cell size was decreased after overeating (P = 0·02). FIAF mRNA levels were decreased after overeating in the RSG group (P = 0·01), with a trend towards a decrease in the placebo group. Unexpectedly, RSG treatment did not influence the expression levels of PPAR¿ and of the PPAR¿ responsive genes aP2, adiponectin and adipsin. In addition, RSG resulted in a larger increase in plasma TAG during overeating than placebo treatment. These results suggest that in healthy, non-obese males the PPAR¿ ligand RSG influences TAG metabolism, independent of its PPAR¿ transcriptional activity in the subcutaneous adipose tissue.

Saved in:
Bibliographic Details
Main Authors: Joosen, A.M.C.P., Bakker, A.H.F., Kersten, A.H., Westerterp, K.R.
Format: Article/Letter to editor biblioteca
Language:English
Subjects:activated-receptor-gamma, alpha, differentiation, gene-expression, in-vivo, insulin-resistance, obesity, protein-kinase, thiazolidinediones, weight,
Online Access:https://research.wur.nl/en/publications/the-ppary-ligand-rosiglitazone-influences-triacylglycerol-metabol
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-wur-nl-wurpubs-369900
record_format koha
spelling dig-wur-nl-wurpubs-3699002024-08-06 Joosen, A.M.C.P. Bakker, A.H.F. Kersten, A.H. Westerterp, K.R. Article/Letter to editor British Journal of Nutrition 99 (2008) 3 ISSN: 0007-1145 The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue 2008 PPAR¿ is obligatory for fat mass generation and is thought to determine the amount of TAG stored per fat cell. We investigated whether ligand availability for PPAR¿ is rate limiting in fat mass generation and substrate metabolism. Twenty healthy men (20¿29 years) were randomly assigned to receive the PPAR¿ ligand rosiglitazone (RSG) (8 mg/d) (n 10) or a placebo (n 10) during a stay of 7 d in a respiration chamber. Food intake was ad libitum, resulting in positive energy balances of 32·2 MJ (placebo) and 44·7 MJ (RSG). Fat cell size and expression of PPAR¿, adipocyte fatty acid-binding protein (aP2), adipsin, adiponectin and fasting-induced adipose factor (FIAF) were determined in subcutaneous abdominal fat biopsies. The total amount of fat stored and the amount of TAG per fat cell were not different between groups. For the entire group, fat cell size was decreased after overeating (P = 0·02). FIAF mRNA levels were decreased after overeating in the RSG group (P = 0·01), with a trend towards a decrease in the placebo group. Unexpectedly, RSG treatment did not influence the expression levels of PPAR¿ and of the PPAR¿ responsive genes aP2, adiponectin and adipsin. In addition, RSG resulted in a larger increase in plasma TAG during overeating than placebo treatment. These results suggest that in healthy, non-obese males the PPAR¿ ligand RSG influences TAG metabolism, independent of its PPAR¿ transcriptional activity in the subcutaneous adipose tissue. en application/pdf https://research.wur.nl/en/publications/the-ppary-ligand-rosiglitazone-influences-triacylglycerol-metabol 10.1017/S0007114507824081 https://edepot.wur.nl/40708 activated-receptor-gamma alpha differentiation gene-expression in-vivo insulin-resistance obesity protein-kinase thiazolidinediones weight Wageningen University & Research
institution WUR NL
collection DSpace
country Países bajos
countrycode NL
component Bibliográfico
access En linea
databasecode dig-wur-nl
tag biblioteca
region Europa del Oeste
libraryname WUR Library Netherlands
language English
topic activated-receptor-gamma
alpha
differentiation
gene-expression
in-vivo
insulin-resistance
obesity
protein-kinase
thiazolidinediones
weight
activated-receptor-gamma
alpha
differentiation
gene-expression
in-vivo
insulin-resistance
obesity
protein-kinase
thiazolidinediones
weight
spellingShingle activated-receptor-gamma
alpha
differentiation
gene-expression
in-vivo
insulin-resistance
obesity
protein-kinase
thiazolidinediones
weight
activated-receptor-gamma
alpha
differentiation
gene-expression
in-vivo
insulin-resistance
obesity
protein-kinase
thiazolidinediones
weight
Joosen, A.M.C.P.
Bakker, A.H.F.
Kersten, A.H.
Westerterp, K.R.
The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue
description PPAR¿ is obligatory for fat mass generation and is thought to determine the amount of TAG stored per fat cell. We investigated whether ligand availability for PPAR¿ is rate limiting in fat mass generation and substrate metabolism. Twenty healthy men (20¿29 years) were randomly assigned to receive the PPAR¿ ligand rosiglitazone (RSG) (8 mg/d) (n 10) or a placebo (n 10) during a stay of 7 d in a respiration chamber. Food intake was ad libitum, resulting in positive energy balances of 32·2 MJ (placebo) and 44·7 MJ (RSG). Fat cell size and expression of PPAR¿, adipocyte fatty acid-binding protein (aP2), adipsin, adiponectin and fasting-induced adipose factor (FIAF) were determined in subcutaneous abdominal fat biopsies. The total amount of fat stored and the amount of TAG per fat cell were not different between groups. For the entire group, fat cell size was decreased after overeating (P = 0·02). FIAF mRNA levels were decreased after overeating in the RSG group (P = 0·01), with a trend towards a decrease in the placebo group. Unexpectedly, RSG treatment did not influence the expression levels of PPAR¿ and of the PPAR¿ responsive genes aP2, adiponectin and adipsin. In addition, RSG resulted in a larger increase in plasma TAG during overeating than placebo treatment. These results suggest that in healthy, non-obese males the PPAR¿ ligand RSG influences TAG metabolism, independent of its PPAR¿ transcriptional activity in the subcutaneous adipose tissue.
format Article/Letter to editor
topic_facet activated-receptor-gamma
alpha
differentiation
gene-expression
in-vivo
insulin-resistance
obesity
protein-kinase
thiazolidinediones
weight
author Joosen, A.M.C.P.
Bakker, A.H.F.
Kersten, A.H.
Westerterp, K.R.
author_facet Joosen, A.M.C.P.
Bakker, A.H.F.
Kersten, A.H.
Westerterp, K.R.
author_sort Joosen, A.M.C.P.
title The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue
title_short The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue
title_full The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue
title_fullStr The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue
title_full_unstemmed The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue
title_sort ppary ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of ppary in the subcutaneous adipose tissue
url https://research.wur.nl/en/publications/the-ppary-ligand-rosiglitazone-influences-triacylglycerol-metabol
work_keys_str_mv AT joosenamcp thepparyligandrosiglitazoneinfluencestriacylglycerolmetabolisminnonobesemaleswithoutincreasingthetranscriptionalactivityofpparyinthesubcutaneousadiposetissue
AT bakkerahf thepparyligandrosiglitazoneinfluencestriacylglycerolmetabolisminnonobesemaleswithoutincreasingthetranscriptionalactivityofpparyinthesubcutaneousadiposetissue
AT kerstenah thepparyligandrosiglitazoneinfluencestriacylglycerolmetabolisminnonobesemaleswithoutincreasingthetranscriptionalactivityofpparyinthesubcutaneousadiposetissue
AT westerterpkr thepparyligandrosiglitazoneinfluencestriacylglycerolmetabolisminnonobesemaleswithoutincreasingthetranscriptionalactivityofpparyinthesubcutaneousadiposetissue
AT joosenamcp pparyligandrosiglitazoneinfluencestriacylglycerolmetabolisminnonobesemaleswithoutincreasingthetranscriptionalactivityofpparyinthesubcutaneousadiposetissue
AT bakkerahf pparyligandrosiglitazoneinfluencestriacylglycerolmetabolisminnonobesemaleswithoutincreasingthetranscriptionalactivityofpparyinthesubcutaneousadiposetissue
AT kerstenah pparyligandrosiglitazoneinfluencestriacylglycerolmetabolisminnonobesemaleswithoutincreasingthetranscriptionalactivityofpparyinthesubcutaneousadiposetissue
AT westerterpkr pparyligandrosiglitazoneinfluencestriacylglycerolmetabolisminnonobesemaleswithoutincreasingthetranscriptionalactivityofpparyinthesubcutaneousadiposetissue
_version_ 1813206088681521152